Experts zero in on key protein in search for coronavirus treatment

03/13/2013 | Bloomberg Businessweek

A new coronavirus that has infected at least 15 people and killed nine in the past year adheres to the DPP4 cell-surface protein, but diabetes drugs that block the protein aren't effective in stopping the virus, and existing antibodies that block the virus also kill somatic cells, according to new research. It is possible the drugs tested on the virus do not block the portion of the protein where the pathogen adheres, so future research will look more deeply into how the virus attaches. Scientists are also testing a potential vaccine, but it would not be available to humans anytime soon.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN